| Class 2 Device Recall Access Thyroglobulin Antibody II Reagent, Part Number: A32898 | |
Date Initiated by Firm | June 29, 2010 |
Date Posted | September 02, 2010 |
Recall Status1 |
Terminated 3 on May 04, 2012 |
Recall Number | Z-2355-2010 |
Recall Event ID |
56214 |
510(K)Number | K062516 |
Product Classification |
immunochemical, thyroglobulin autoantibody - Product Code JNL
|
Product | Beckman Coulter Access Thyroglobulin Antibody II Reagent, Part Number: A32898. The Access Thyroglobulin Antibody II (TgAb) assay intended use is for the quantitative determination of thyroglobulin antibody levels in human serum and plasma using the Access Immunoassay Systems. |
Code Information |
Lot Numbers: 917073, 918433 & 916271 |
Recalling Firm/ Manufacturer |
Beckman Coulter Inc. 200 S Kraemer Blvd Brea CA 92821-6208
|
For Additional Information Contact | Clair K. ODonovan, Ph.D. 714-961-4483 |
Manufacturer Reason for Recall | The affected Access Thyroglobulin Antibody II reagent may produce inaccurate results due to a change in the thyroglobulin that was used in the kits.
|
FDA Determined Cause 2 | Other |
Action | Beckman Coulter sent an "Urgent Product Corrective Action" letter dated June 29, 2010, with attached Customer Response form to the affected customers. The letter identified the affected product and issue.
Customers were instructed to:
(1) Discontinue use of Access Thyroglobulin Antibody II reagent lot numbers 916271, 917073, and 918433.
(2) Review results in the context of the total clinical presentation of the patient, and rerun questionable results using another reagent.
(3) Complete and return a response form within 10 days.
(4) For replacement contact Beckman Coulter at (US) 1-800-526-3821, (Canada) 1-800-463-7828.
Customer Technical Support can be contacted at 1-800-854- 3633. |
Quantity in Commerce | 1071 units |
Distribution | Worldwide distribution : United States, including states of CA, CO, FL, GA. IA, IL, KY, MA, MD, MI, MN, MO, MS, NC, NJ, NY, OH, PA, RI, SC, SD, TN, TX, UT, VA, WA, and WI, and country of Canada. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = JNL
|
|
|
|